Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2018
Systematic analysis of copy number variation associated with congenital diaphragmatic herniaQihui Zhu, Frances A High, Chengsheng Zhang, et al.
Transplantation and Cellular Therapy|January 8, 2025
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More TherapiesEdward Abadir, Rebecca Wayte, Wenlong Li, et al.
Blood Advances|May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16Peter Mollee, John Reynolds, Wojt Janowski, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Scientific Reports|April 14, 2021
A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profilingJeremy W Roy, Catherine A Taylor, Annie P Beauregard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2026
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort studyGemma K Reynolds, Mark R Dowling, Safia Belbachir, et al.
Molecular Oncology|July 25, 2019
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiationEdward Abadir, Robin E Gasiorowski, Kaitao Lai, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2026
Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk GroupsGhassan Zammar, Bradley Augustson, Elizabeth Moore, et al.
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
International Immunopharmacology|June 9, 2023
Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human plateletsMathieu P A Hébert, Ayyoub Selka, Andréa A Lebel, et al.
Pageof 26